U.S. Ophthalmic Compounding Pharmacies Market Rapidly Increasing Growth Latest Report With Future Estimations, Current Trends And Opportunity Analysis 2021-2028
Drug compounding is the process of combining, mixing, or changing substances to create a treatment tailored to the needs of a specific patient. The process of combining two or more medications is known as compounding. Individual chemicals are combined in the precise strength and dosage form required by the patient. Compounded drugs are created in response to a practitioner's request. The ingredients are regulated by the United States Food and Drug Administration (FDA), which generally consists of drugs that have undergone FDA clinical trials and received approval. When a patient cannot be treated with a U.S. Food and Drug Administration (FDA) approved drug, such as when a patient is allergic to a dye in a medicine, compounding is used.
The U.S. Ophthalmic Compounding Pharmacies Market is expected to grow dramatically in the coming years as a result of rising product adoption among the elderly population, increased demand for tablets and syrups, increased need for hormone replacement, and favourable analogue medical X-ray system preference among healthcare professionals. The increasing use of sterile preparations, such as parenteral and ophthalmic dosage forms, in the treatment of various chronic diseases will drive market growth.
The traditional role of compounding pharmacies is to prepare medicines prescribed by specialists for specific patients who have needs that cannot be met by commonly available drugs. According to the International Association of Community Pharmacies, there are approximately 56,000 community-based pharmacies in the United States. Almost half of them work directly with doctors as well as local patients. The compounding pharmacies market in the United States is divided into several segments based on pharmacy type, sterility, product, application, therapeutic area, and compounding type.
Market Segmentation:
By Formulation
- Eye Drops
- Ointments
- Injections
- Others
By Therapeutic Application
- Dry Eyes
- Glaucoma
- Cataracts
- Conjunctivitis
- Age-related Macular Degeneration
- Uveitis (Eye Inflammation)
- Others
- 503A
- 503B
Comments
Post a Comment